You are here: Industry Insights > PPD

News List

Thermo Fisher acquires clinical research services provider PPD for $17.4bn Pharmaceutical-Technology
December 10, 2021
With the acquisition, PPD will be part of Thermo Fisher’s Laboratory Products and Services unit.
PPD Opens Clinical Research Lab in Suzhou contractpharma
May 25, 2021
PPD, Inc., a global CRO, opened new multipurpose lab in Suzhou, China, to support Western and China-based pharma and biopharma companies managing China research studies.
PPD to Expand GMP Lab in Ireland contractpharma
April 30, 2021
PPD, Inc., a global contract research organization (CRO), is expanding its Athlone, Ireland, GMP laboratory, increasing the size of its current facility and adding cell and gene therapy testing to the operation’s portfolio of services.
PPD, Science 37 Partner to Advance Decentralized Trials contractpharma
April 29, 2021
PPD will leverage Science 37's DCT SaaS-based technology platform to design, build, test, implement and execute digital trials.
Thermo Fisher acquires PPD, a CRO, in $17.4 billion deal expresspharma
April 19, 2021
Thermo Fisher Scientific said it would acquire contract researcher PPD for $17.4 billion as it looks to add more muscle to its pharmaceutical services business.
Thermo Fisher Acquires PPD for $17.4B contractpharma
April 16, 2021
Thermo Fisher Scientific has acquired clinical research services provider PPD for $17.4 billion.
PPD, Clinical Ink Partner on Near Real-Time Access to Endpoint Data contractpharma
March 25, 2021
PPD, Inc., a global CRO, and Clinical Ink, a global clinical technology company, have jointly developed a systemic lupus erythematosus (SLE) assessment review process designed to simplify operationalizing clinical trials for this chronic autoimmune ...
PPD Awarded US Army RPA Develop PTSD Drugs contractpharma
February 20, 2021
PPD, Inc., a global CRO, has been awarded Defense Health Agency funds to support a five-year Research Project Award (RPA) to develop and execute an adaptive platform clinical research trial of drug interventions to treat post-traumatic stress disorder.
Financial Report: PPD contractpharma
October 30, 2020
Comments: Clinical Development Services revenue was $1.0 billion in the quarter, up 19% and Laboratory Services revenue was $225.2 million, up 27%.
PPD to Open Multipurpose Clinical Research Lab in Suzhou contractpharma
October 16, 2020
PPD, Inc. is opening a new lab in Suzhou, China, to support China-based biopharma companies and Western pharmaceutical companies managing research studies in China.

Previous page 1 2 3 Next page